Ajax-Loading

Sino Biopharmaceutical Ltd - Debt To Equity Ratio

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December.

The item "Debt-To-Equity-Ratio" stands at 0.3557 as of 06/30/2025, the highest value since 03/31/2024.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Debt To Equity Ratio" stands at 0.3557. This represents an increase of 33.81 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.71 percent compared to the value the year prior.
The 1 year change in percent is 22.71.
The 3 year change in percent is -8.49.

The Serie's long term average value is 0.329. It's latest available value, on 06/30/2025, is 8.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is +160.99%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 06/30/2025, is -23.29%.

Debt To Equity Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Equity Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Equity Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Equity Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Equity Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Equity Ratio280,205,508,085.11